Melanoma antigen peptide and uses thereof
US9475841B2 · kind B2 · utility
1Cited by
1References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 22, 2012 |
| Grant date | Oct 25, 2016 |
| Priority date | — |
| Expiry date | May 22, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected in the group consisting of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14 or SEQ ID NO: 15 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.